<p>Absci 公司（NASDAQ:ABSI - 获取免费报告）的股票获得了七家覆盖该公司的券商一致推荐的 “买入” 评级，MarketBeat.com 报道。七位投资分析师对该股票给予了买入评级。在过去一年中，覆盖该股票的券商的平均一年目标价为 8.57 美元。</p>
<p>一些股票研究分析师最近对 ABSI 股票发表了评论。KeyCorp 在 1 月 8 日的研究报告中将 Absci 的目标价从 6.00 美元下调至 5.00 美元，并对该股票设定了 “增持” 评级。HC Wainwright 在 1 月 17 日的研究报告中重申了 “买入” 评级，并将 Absci 的目标价设定为 7.00 美元。Needham &amp; Company LLC 在 1 月 22 日的研究报告中开始覆盖 Absci，给予了 “买入” 评级，并设定了 9.00 美元的目标价。最后，Guggenheim 在 12 月 3 日的研究报告中重申了 “买入” 评级，并将 Absci 的目标价设定为 10.00 美元。</p>
<p><strong>查看我们最新的 Absci 研究报告</strong></p>
<h2>Absci 股票上涨 0.2%</h2>
<p>ABSI 的股票在周二以 4.72 美元开盘。该公司的市值为 5.4214 亿美元，市盈率为-5.08，贝塔值为 2.11。该股票的 50 日移动平均价格为 3.33 美元，200 日移动平均价格为 3.69 美元。该公司的流动比率为 5.63，速动比率为 5.63，债务与股本比率为 0.01。Absci 的 12 个月低点为 2.45 美元，12 个月高点为 6.72 美元。</p>
<p>Absci（NASDAQ:ABSI - 获取免费报告）最近在 11 月 12 日发布了季度财报。该公司报告季度每股收益为（0.24 美元），低于分析师一致预期的（0.19 美元）0.05 美元。该季度的收入为 170 万美元，而分析师预期为 177 万美元。Absci 的股本回报率为-46.56%，净利润率为-2321.56%。在去年同期，该公司每股收益为（0.24 美元）。分析师预计 Absci 在本年度的每股收益将为-0.89 美元。</p>
<h2>机构资金流入和流出</h2>
<p>机构投资者最近增加或减少了对该公司的持股。Dimensional Fund Advisors LP 在第二季度将其在 Absci 的持股增加了 88.0%。Dimensional Fund Advisors LP 目前拥有 125,089 股该公司的股票，价值 385,000 美元，此前在上一季度增持了 58,556 股。蒙特利尔银行在第二季度收购了 Absci 的新股份，价值 527,000 美元。制造商人寿保险公司在第二季度购买了 Absci 的新股份，价值 100,000 美元。IQ EQ FUND MANAGEMENT IRELAND Ltd 在第三季度收购了 Absci 的新股份，价值 53,000 美元。最后，Cherry Creek Investment Advisors Inc.在第三季度购买了 Absci 的新股份，价值 149,000 美元。52.05% 的股票由机构投资者和对冲基金持有。</p>
<h2>Absci 公司简介</h2>
<p>（获取免费报告）</p>
<p>Absci 公司在美国作为一家数据优先的生成性人工智能（AI）药物创制公司运营。该公司将人工智能与可扩展的湿实验室技术相结合，为患者创造生物制剂。其集成药物创制平台旨在通过使用人工智能同时优化多个可能对开发和治疗效果重要的药物特性，从而改进传统的生物药物发现。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Absci 更好</li>
<li>3 只超市股票证明它们仍然是必需品</li>
<li>Roblox 价格暴跌为强劲收益提供机会</li>
<li>ETF 是否支付股息？你需要知道的事情</li>
<li>数十亿美元的回购：4 只股票现在回馈股东</li>
<li>3 只股票引领网络股票复兴</li>
<li>3 只钢铁股票在关税重塑市场时将获得力量</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUJTSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUJTSQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元吗？</h2>
<p>在你进行下一笔交易之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。</p>
<p>我们的团队已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在购买，以便在更广泛的市场注意到之前...而且没有大名鼎鼎的股票在名单上。</p>
<p>他们认为这五只股票是投资者现在购买的五家最佳公司...</p>
<p>查看这五只股票</p>
<h2>你现在应该投资 1000 美元在 Absci 吗？</h2>
<p>在你考虑 Absci 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在购买，以便在更广泛的市场注意到之前...而 Absci 不在名单上。</p>
<p>虽然 Absci 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ABSI

<p>Absci 公司（NASDAQ:ABSI）获得了七家券商的一致 “买入” 评级，平均目标价为 8.57 美元。KeyCorp 将其目标价从 6.00 美元下调至 5.00 美元，而 HC Wainwright 设定了 7.00 美元的目标。Needham 首次覆盖，目标价为 9.00 美元，Guggenheim 设定了 10.00 美元的目标。Absci 的股票开盘价为 4.72 美元，市值为 5.4214 亿美元。该公司报告的季度每股收益为（0.24 美元），未达到预期，收入为 170 万美元，低于预期</p>

<p>Shares of Absci Co. (NASDAQ:ABSI - Get Free Report) have received a consensus recommendation of &#34;Buy&#34; from the seven brokerages that are covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have covered the stock in the last year is $8.57.</p>
<div class="lb-trans"><p>Absci 公司（NASDAQ:ABSI - 获取免费报告）的股票获得了七家覆盖该公司的券商一致推荐的 “买入” 评级，MarketBeat.com 报道。七位投资分析师对该股票给予了买入评级。在过去一年中，覆盖该股票的券商的平均一年目标价为 8.57 美元。</p>
</div><p>A number of equities research analysts have recently commented on ABSI shares. KeyCorp reduced their price objective on shares of Absci from $6.00 to $5.00 and set an &#34;overweight&#34; rating on the stock in a research note on Wednesday, January 8th. HC Wainwright reaffirmed a &#34;buy&#34; rating and set a $7.00 price target on shares of Absci in a research report on Friday, January 17th. Needham &amp; Company LLC initiated coverage on Absci in a research report on Wednesday, January 22nd. They issued a &#34;buy&#34; rating and a $9.00 price objective for the company. Finally, Guggenheim restated a &#34;buy&#34; rating and set a $10.00 target price on shares of Absci in a research report on Tuesday, December 3rd.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对 ABSI 股票发表了评论。KeyCorp 在 1 月 8 日的研究报告中将 Absci 的目标价从 6.00 美元下调至 5.00 美元，并对该股票设定了 “增持” 评级。HC Wainwright 在 1 月 17 日的研究报告中重申了 “买入” 评级，并将 Absci 的目标价设定为 7.00 美元。Needham &amp; Company LLC 在 1 月 22 日的研究报告中开始覆盖 Absci，给予了 “买入” 评级，并设定了 9.00 美元的目标价。最后，Guggenheim 在 12 月 3 日的研究报告中重申了 “买入” 评级，并将 Absci 的目标价设定为 10.00 美元。</p>
</div><p><strong>View Our Latest Research Report on Absci</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Absci 研究报告</strong></p>
</div><h2>Absci Stock Up 0.2 %</h2>
<div class="lb-trans"><h2>Absci 股票上涨 0.2%</h2>
</div><p>Shares of ABSI opened at $4.72 on Tuesday. The company has a market capitalization of $542.14 million, a PE ratio of -5.08 and a beta of 2.11. The stock's 50-day moving average price is $3.33 and its two-hundred day moving average price is $3.69. The company has a current ratio of 5.63, a quick ratio of 5.63 and a debt-to-equity ratio of 0.01. Absci has a 12 month low of $2.45 and a 12 month high of $6.72.</p>
<div class="lb-trans"><p>ABSI 的股票在周二以 4.72 美元开盘。该公司的市值为 5.4214 亿美元，市盈率为-5.08，贝塔值为 2.11。该股票的 50 日移动平均价格为 3.33 美元，200 日移动平均价格为 3.69 美元。该公司的流动比率为 5.63，速动比率为 5.63，债务与股本比率为 0.01。Absci 的 12 个月低点为 2.45 美元，12 个月高点为 6.72 美元。</p>
</div><p>Absci (NASDAQ:ABSI - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.05). The company had revenue of $1.70 million during the quarter, compared to analyst estimates of $1.77 million. Absci had a negative return on equity of 46.56% and a negative net margin of 2,321.56%. During the same period in the prior year, the firm earned ($0.24) earnings per share. On average, analysts anticipate that Absci will post -0.89 EPS for the current year.</p>
<div class="lb-trans"><p>Absci（NASDAQ:ABSI - 获取免费报告）最近在 11 月 12 日发布了季度财报。该公司报告季度每股收益为（0.24 美元），低于分析师一致预期的（0.19 美元）0.05 美元。该季度的收入为 170 万美元，而分析师预期为 177 万美元。Absci 的股本回报率为-46.56%，净利润率为-2321.56%。在去年同期，该公司每股收益为（0.24 美元）。分析师预计 Absci 在本年度的每股收益将为-0.89 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its holdings in shares of Absci by 88.0% during the second quarter. Dimensional Fund Advisors LP now owns 125,089 shares of the company's stock valued at $385,000 after acquiring an additional 58,556 shares in the last quarter. Bank of Montreal Can acquired a new stake in Absci in the 2nd quarter valued at $527,000. The Manufacturers Life Insurance Company bought a new stake in Absci during the 2nd quarter valued at $100,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in Absci during the third quarter worth $53,000. Finally, Cherry Creek Investment Advisors Inc. bought a new position in shares of Absci in the third quarter valued at $149,000. 52.05% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>机构投资者最近增加或减少了对该公司的持股。Dimensional Fund Advisors LP 在第二季度将其在 Absci 的持股增加了 88.0%。Dimensional Fund Advisors LP 目前拥有 125,089 股该公司的股票，价值 385,000 美元，此前在上一季度增持了 58,556 股。蒙特利尔银行在第二季度收购了 Absci 的新股份，价值 527,000 美元。制造商人寿保险公司在第二季度购买了 Absci 的新股份，价值 100,000 美元。IQ EQ FUND MANAGEMENT IRELAND Ltd 在第三季度收购了 Absci 的新股份，价值 53,000 美元。最后，Cherry Creek Investment Advisors Inc.在第三季度购买了 Absci 的新股份，价值 149,000 美元。52.05% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Absci Company Profile</h2>
<div class="lb-trans"><h2>Absci 公司简介</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit.</p>
<div class="lb-trans"><p>Absci 公司在美国作为一家数据优先的生成性人工智能（AI）药物创制公司运营。该公司将人工智能与可扩展的湿实验室技术相结合，为患者创造生物制剂。其集成药物创制平台旨在通过使用人工智能同时优化多个可能对开发和治疗效果重要的药物特性，从而改进传统的生物药物发现。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Absci</li>
<li>3 Grocery Stocks That Are Proving They Are Still Essential</li>
<li>Price Plunge in Roblox Presents Opportunity for Robust Gains</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Billions in Buybacks: 4 Stocks Rewarding Shareholders Now</li>
<li>3 Tickers Leading a Meme Stock Revival</li>
<li>3 Steel Stocks to Gain Strength as Tariffs Reshape the Market</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Absci 更好</li>
<li>3 只超市股票证明它们仍然是必需品</li>
<li>Roblox 价格暴跌为强劲收益提供机会</li>
<li>ETF 是否支付股息？你需要知道的事情</li>
<li>数十亿美元的回购：4 只股票现在回馈股东</li>
<li>3 只股票引领网络股票复兴</li>
<li>3 只钢铁股票在关税重塑市场时将获得力量</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUJTSQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ABSI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Where Should You Invest $1,000 Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元吗？</h2>
</div><p>Before you make your next trade, you'll want to hear this.</p>
<div class="lb-trans"><p>在你进行下一笔交易之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。</p>
</div><p>Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p>
<div class="lb-trans"><p>我们的团队已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在购买，以便在更广泛的市场注意到之前...而且没有大名鼎鼎的股票在名单上。</p>
</div><p>They believe these five stocks are the five best companies for investors to buy now...</p>
<div class="lb-trans"><p>他们认为这五只股票是投资者现在购买的五家最佳公司...</p>
</div><p>See The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div><h2>Should You Invest $1,000 in Absci Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Absci 吗？</h2>
</div><p>Before you consider Absci, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Absci 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Absci wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在购买，以便在更广泛的市场注意到之前...而 Absci 不在名单上。</p>
</div><p>While Absci currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Absci 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Absci Co. (NASDAQ:ABSI) Receives $8.57 Average Price Target from Brokerages

Market Beat

Absci 公司（纳斯达克股票代码：ABSI）获得券商 8.57 美元的平均目标价